Development of a sensitive and selective assay for the determination of procarboxypeptidase U (thrombin-activatable fibrinolysis inhibitor) in plasma
Author:
Publisher
Elsevier BV
Subject
Cell Biology,Molecular Biology,Biochemistry,Biophysics
Reference17 articles.
1. A labile enzyme in fresh human serum interferes with the assay of carboxypeptidase N;Hendriks;Clin. Chem.,1989
2. Purification and characterization of TAFI, a thrombin-activable fibrinolysis inhibitor;Bajzar;J. Biol. Chem.,1995
3. Discovery of thrombin activatable fibrinolysis inhibitor (TAFI);Hendriks;J. Thromb. Haemost.,2005
4. A role for procarboxypeptidase U (TAFI) in thrombosis;Willemse;Front. Biosci.,2007
5. Carboxypeptidase U (TAFIa) prevents lysis from proceeding into the propagation phase through a threshold-dependent mechanism;Leurs;J. Thromb. Haemost.,2004
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Atorvastatin downregulates plasma procarboxypeptidase U concentrations and improves fibrinolytic potential dose-dependently in hyperlipidemic individuals;Journal of Thrombosis and Haemostasis;2023-05
2. Assays to quantify fibrinolysis: strengths and limitations. Communication from the International Society on Thrombosis and Haemostasis Scientific and Standardization Committee on fibrinolysis;Journal of Thrombosis and Haemostasis;2023-04
3. ProCPU Is Expressed by (Primary) Human Monocytes and Macrophages and Expression Differs between States of Differentiation and Activation;International Journal of Molecular Sciences;2023-02-13
4. Structure/characteristics of thrombin activatable fibrinolysis inhibitor (TAFI) and its assay method;Japanese Journal of Thrombosis and Hemostasis;2023
5. Activation of the Carboxypeptidase U (CPU, TAFIa, CPB2) System in Patients with SARS-CoV-2 Infection Could Contribute to COVID-19 Hypofibrinolytic State and Disease Severity Prognosis;Journal of Clinical Medicine;2022-03-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3